Jane Street’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1M Buy
1,590,513
+908,331
+133% +$13.9M ﹤0.01% 1700
2026
Q1
$9.47M Buy
+682,182
New +$10.9M ﹤0.01% 2608
2025
Q4
Sell
-109,312
Closed -$1.78M 10976
2025
Q3
$1.64M Buy
+109,312
New +$1.33M ﹤0.01% 5309
2025
Q2
Sell
-43,272
Closed -$322K 9503
2025
Q1
$322K Sell
43,272
-363,315
-89% -$2.79M ﹤0.01% 7688
2024
Q4
$2.44M Sell
406,587
-97,690
-19% -$539K ﹤0.01% 3764
2024
Q3
$2.58M Sell
504,277
-517,256
-51% -$2.25M ﹤0.01% 3980
2024
Q2
$3.7M Buy
1,021,533
+923,848
+946% +$2.93M ﹤0.01% 3445
2024
Q1
$314K Sell
97,685
-78,545
-45% -$304K ﹤0.01% 7490
2023
Q4
$864K Buy
176,230
+144,264
+451% +$658K ﹤0.01% 5817
2023
Q3
$174K Sell
31,966
-47,924
-60% -$317K ﹤0.01% 7713
2023
Q2
$536K Buy
79,890
+41,901
+110% +$312K ﹤0.01% 6214
2023
Q1
$335K Sell
37,989
-30,867
-45% -$272K ﹤0.01% 7004
2022
Q4
$526K Buy
68,856
+51,047
+287% +$397K ﹤0.01% 6043
2022
Q3
$127K Buy
+17,809
New +$168K ﹤0.01% 8510
2022
Q2
Sell
-228,889
Closed -$2.01M 9533
2022
Q1
$3.18M Buy
228,889
+210,530
+1,147% +$3.31M ﹤0.01% 3831
2021
Q4
$516K Sell
18,359
-10,685
-37% -$328K ﹤0.01% 7209
2021
Q3
$987K Buy
29,044
+17,451
+151% +$631K ﹤0.01% 5932
2021
Q2
$473K Sell
11,593
-40,019
-78% -$1.56M ﹤0.01% 7351
2021
Q1
$2.08M Buy
51,612
+41,144
+393% +$2.23M ﹤0.01% 3939
2020
Q4
$619K Sell
10,468
-42,789
-80% -$2.21M ﹤0.01% 5426
2020
Q3
$2.59M Buy
53,257
+32,229
+153% +$1.35M ﹤0.01% 2647
2020
Q2
$1.02M Buy
21,028
+10,132
+93% +$369K ﹤0.01% 4039
2020
Q1
$303K Buy
+10,896
New +$304K ﹤0.01% 4193

Other funds holding ADPT

Jane Street's ADPT Position: Q2 2026 in Review

Jane Street increased its Adaptive Biotechnologies (ADPT) stake by 133% in Q2 2026, buying an estimated $13.9M and bringing the position to 1,590,513 shares worth $34.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Jane Street first reported a position in ADPT in Q1 2020 and has held it in 23 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Jane Street held 1,590,513 shares of Adaptive Biotechnologies worth $34.1M as of Q2 2026.
  • Jane Street bought 908,331 Adaptive Biotechnologies shares in Q2 2026, an estimated $13.9M.
  • Adaptive Biotechnologies made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1700 holding.
  • Jane Street first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 23 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.